Zobrazeno 1 - 10
of 440
pro vyhledávání: '"First remission"'
Autor:
Xavier Poiré, Myriam Labopin, Johan Maertens, Ibrahim Yakoub-Agha, Didier Blaise, Norbert Ifrah, Gérard Socié, Tobias Gedde-Dhal, Nicolaas Schaap, Jan J. Cornelissen, Stéphane Vigouroux, Jaime Sanz, Lucienne Michaux, Jordi Esteve, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-10 (2017)
Abstract Background Acute myeloid leukaemia (AML) with 17p abnormalities (abn(17p)) carries a very poor prognosis due to high refractoriness to conventional chemotherapy, and allogeneic stem cell transplantation (allo-SCT) appears as the only potenti
Externí odkaz:
https://doaj.org/article/6a4d07d155f249919081184aad43d067
Autor:
E S Nesterova, S K Kravchenko, Ya K Mangasarova, E A Baryakh, A E Misyurina, V I Vorobyev, L V Plastinina, N G Chernova, A M Kovrigina, T N Obukhova, G A Klyasova, A A Shevelev, I E Kostina, E G Gemdzhian, T V Gaponova, A I Vorobyev
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 62-71 (2016)
Aim: To evaluate the efficiency of high-dose chemotherapy (HDCT) with further autologous blood stem cell transplantation (auto-BSCT) in the first-line therapy of patients with follicular lymphoma (FL) and poor prognostic factors. Subjects and methods
Externí odkaz:
https://doaj.org/article/8a0d44c2097f492685b978067c7c045b
Autor:
Stuart Peacock, Corneliu Bolbocean, Aly Karsan, Dean A. Regier, Donna E. Hogge, Sonya Cressman, Emily McPherson
Publikováno v:
British Journal of Haematology
Summary Acute Myeloid Leukaemia (AML) is a rare but serious group of diseases that require critical decision-making for curative treatment. Over the past decade, scientific discovery has revealed dozens of prognostic gene mutations for AML while sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ed6e2cf624c367fbba849d92e9bd37
https://doi.org/10.1111/bjh.14076
https://doi.org/10.1111/bjh.14076
Autor:
T.Yu. Semiglazova Semiglazova, L.V. Filatova Filatova, I.V. Ishmatova Ishmatova, M. S. Motalkina, A.K. Kovyazin Kovyazin, Yu.A. Chudinovskikh Chudinovskikh, E.V. Cherkasova Cherkasova, S.A. Shalaev Shalaev, S.A. Volchenkov Volchenkov, A.A. Zverkova Zverkova, I.S. Zyuzgin Zyuzgin
Publikováno v:
Pharmateca. :42-50
Autor:
Kai-Yan Liu, Wei Han, Xiao-Hui Zhang, Yan-Ru Ma, Meng Lv, Ying-Jun Chang, Feng-Rong Wang, Chen-Hua Yan, Yu-Hong Chen, Xiao-Jun Huang, Xiao-Dong Mo, Yu Wang, Lan-Ping Xu
Publikováno v:
Annals of Hematology. 100:555-562
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and curative treatment for acute myeloid leukemia (AML). We explored the outcome of haploidentical donor (HID) transplantation for intermediate-risk AML and compared to th
Autor:
S N Bondarenko, E V Semenova, V N Vavilov, N V Stancheva, E V Morozova, A L Alianskiĭ, E V Babenko, N É Osipova, L S Zubarovskaia, B V Afanas'ev
Publikováno v:
Терапевтический архив, Vol 85, Iss 7, Pp 18-25 (2013)
AIM: To evaluate the efficiency of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloblastic leukemia in first remission depending on the regimens of conditioning, the source of a graft, and the characteristic
Externí odkaz:
https://doaj.org/article/e883163b23a9453aafb7a0447471fb85
Autor:
R.L. Bayer, Jerald P. Radich, Maria Brown, M. Lynn Savoie, Bruno C. Medeiros, Harry P. Erba, John M. Pagel, Selina M. Luger, Stephen A. Strickland, Sanjay R. Mohan, Guillermo Garcia-Manero, Dennis L. Confer, David A. Rizzieri, Stephen R. Spellman, Richard Stone, Geoffrey L. Uy, David F. Claxton, Mark R. Litzow, Min Fang, Frederick R. Appelbaum, Megan Othus, Mikkael A. Sekeres, Jeffrey Chell, Bayard L. Powell, James Essell, Guido Marcucci, Anna Moseley, Richard A. Larson, Tara L. Lin
Publikováno v:
JCO Oncol Pract
PURPOSE: Patients with acute myeloid leukemia with high-risk cytogenetics in first complete remission (CR1) achieve better outcomes if they undergo allogeneic hematopoietic cell transplantation (HCT) compared with consolidation chemotherapy alone. Ho
Autor:
Yasushi Miyazaki, Naomi Kawashima, Heiwa Kanamori, Maki Hagihara, Norio Asou, Kensuke Usuki, Hitoshi Kiyoi, Tomoki Naoe, Miki Kobayashi, Shigeki Ohtake, Yoshiko Atsuta, Masashi Sawa, Akio Kohno, Yuichi Ishikawa, Tomoya Maeda, Masaki Hayashi, Itaru Matsumura, Hiroshi Matsuoka, Akihiro Tomita, Emiko Sakaida, Yukiyasu Ozawa
Publikováno v:
Cancer Science
In this phase II multicenter study (JALSG AML209‐FLT3‐SCT), we aimed to prospectively elucidate the role of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) at first complete remission (CR1) for FLT3‐internal tandem duplication
Publikováno v:
Journal of Hematology
Identification of chromosomal abnormalities in patients with acute myeloid leukemia (AML) has contributed substantially to our current understanding of the molecular pathogenesis underlying leukemogenesis, and risk-stratification based on molecular a
Autor:
Steen Rosthøj, Birgitte Klug Albertsen, Henrik Daa Schrøder, Karen Schow Jensen, Kjeld Schmiegelow, Alina Zalounina Falborg, Peter Vedsted, Michael Callesen
Publikováno v:
Jensen, K S, Klug Albertsen, B, Schrøder, H, Zalounina Falborg, A, Schmiegelow, K, Rosthøj, S, Callesen, M T & Vedsted, P 2021, ' Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia : a population-based matched cohort study ', BMJ Open, vol. 11, no. 8, e050285 . https://doi.org/10.1136/bmjopen-2021-050285
BMJ Open, Vol 11, Iss 8 (2021)
BMJ Open
Jensen, K S, Klug Albertsen, B, Schrøder, H, Zalounina Falborg, A, Schmiegelow, K, Rosthøj, S, Callesen, M T & Vedsted, P 2021, ' Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia : A population-based matched cohort study ', BMJ Open, vol. 11, no. 8, e050285 . https://doi.org/10.1136/bmjopen-2021-050285
Jensen, K S, Klug Albertsen, B, Schrøder, H, Zalounina Falborg, A, Schmiegelow, K, Rosthøj, S, Callesen, M T & Vedsted, P 2021, ' Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia : A population-based matched cohort study ', BMJ Open, vol. 11, no. 8, e050285, pp. e050285 . https://doi.org/10.1136/bmjopen-2021-050285
BMJ Open, Vol 11, Iss 8 (2021)
BMJ Open
Jensen, K S, Klug Albertsen, B, Schrøder, H, Zalounina Falborg, A, Schmiegelow, K, Rosthøj, S, Callesen, M T & Vedsted, P 2021, ' Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia : A population-based matched cohort study ', BMJ Open, vol. 11, no. 8, e050285 . https://doi.org/10.1136/bmjopen-2021-050285
Jensen, K S, Klug Albertsen, B, Schrøder, H, Zalounina Falborg, A, Schmiegelow, K, Rosthøj, S, Callesen, M T & Vedsted, P 2021, ' Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia : A population-based matched cohort study ', BMJ Open, vol. 11, no. 8, e050285, pp. e050285 . https://doi.org/10.1136/bmjopen-2021-050285
ObjectivesTo investigate health care utilisation including both primary and secondary health care 6 months before the diagnosis of a relapse or a second malignant neoplasm (SMN) in survivors of childhood acute lymphoblastic leukaemia (ALL).Design and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a235f763626a0dd438a9260b5bd547b
https://vbn.aau.dk/ws/files/441888781/Jensen_et_al_2021_Health_care_utilisation_preceding_relapse_or_second_malignant_neoplasm_after_childhood_acute_lymphoblastic_leukaemia.pdf
https://vbn.aau.dk/ws/files/441888781/Jensen_et_al_2021_Health_care_utilisation_preceding_relapse_or_second_malignant_neoplasm_after_childhood_acute_lymphoblastic_leukaemia.pdf